1. Glucagon-Like Peptide-1 Receptor Agonists and Brain Vascular Function.
- Author
-
Begic, Edin and Causevic, Mirsada
- Subjects
- *
GLUCAGON-like peptide-1 receptor , *GLUCAGON-like peptide-1 agonists , *GLUCAGON-like peptide 1 , *ENDOTHELIUM diseases , *THERAPEUTICS , *ATHEROSCLEROSIS prevention , *BRAIN , *CARDIOVASCULAR diseases , *ATHEROSCLEROSIS , *TYPE 2 diabetes , *CARDIOVASCULAR agents - Abstract
Prevention of cardiovascular events and regression of atherosclerotic changes are the primary aims of preventive cardiovascular medicine. Arterial thrombosis is caused by endothelial dysfunction, which disrupts vascular haemostasis. Glucagon-like peptide 1 (GLP-1) receptor agonists have been initially used as glucose lowering agents, but over time have been used for other indications due to their cardiorenal benefit, as well as their benefit in the regression of atherosclerosis process. The aim of this paper is to present the benefits of GLP-1 receptor agonists in the prevention of atherosclerotic changes, in the preservation of brain vascular function, and to show the possible role in the treatment of neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF